-
Bin Guan, PhD,
Johns Hopkins University School of Medicine
Mentored Investigator Grant
Functional Characterization of the Tumor Suppressor ARID1A in Ovarian Cancer
-
Karen Cowden Dahl, PhD,
Indiana University
Early Career Investigator Grant
Investigation of ARID3B Splicing as a Novel Therapeutic Target for Ovarian Cancer
-
Kate Lawrenson, PhD,
University of Southern California
Mentored Investigator Grant
Modeling Stem Cell Origins of Epithelial Ovarian Carcinomas
-
Hanqing Liu, PhD,
Fox Chase Cancer Center
Mentored Investigator Grant
Targeting Signaling Networks via RNAi to Improve Therapy for Ovarian Cancer
-
Daniela Dinulescu, PhD,
Brigham and Women’s Hospital
Early Career Investigator Grant
Modeling Serous Ovarian Carcinoma Using Genetic Markers Specific for the Distal Fallopian Tube
-
George Coukos, M.D., Ph.D.,
University of Pennsylvania
Collaborative Research Development Grant
Engineering Immune Cells to Better Recognize and Kill Ovarian Cancer
-
Ngai Na Co, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
The Role of Stromal microRNA 21 in Omental Ovarian Cancer Progression
-
Ivan Garcia-Bassets, PhD,
University of California - San Diego
Early Career Investigator Grant
Targeting the Epigenetic Plasticity of the Platinum Response in Drug-resistant Ovarian Cancer Cells
-
Ernst Lengyel, MD, PhD,
University of Chicago
Collaborative Research Development Grant
Reprogramming of Ovarian Cancer Microenvironments by miRNAs
-
Shannon Hawkins, MD, PhD,
Baylor College of Medicine
Early Career Investigator Grant
The Function of ARID1A in the Transformation of Endometriosis to Ovarian Cancer
-
See-Hyoung Park, PhD,
Stanford University
Mentored Investigator Grant
Targeting Ovarian Cancer with Combination of Olaparib and Bepridil
-
Martin Matthew Matzuk, MD, PhD,
Baylor College of Medicine
Collaborative Research Development Grant
Diagnostic Strategies for Detection of Ovarian Cancer
-
W. Ruprecht Wiedemeyer, PhD,
Cedars-Sinai Medical Center
Early Career Investigator Grant
Ovarian Cancer Evolution After Targeted Therapy
-
Melinda Yates, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Unraveling the Initiation of Ovarian Cancer: The BRCA1-Heterozygous Mouse as a Model System